These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26801880)

  • 1. Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.
    Dickinson SE; Janda J; Criswell J; Blohm-Mangone K; Olson ER; Liu Z; Barber C; Petricoin EF; Calvert VS; Einspahr J; Dickinson JE; Stratton SP; Curiel-Lewandrowski C; Saboda K; Hu C; Bode AM; Dong Z; Alberts DS; Timothy Bowden G
    Cancer Prev Res (Phila); 2016 Mar; 9(3):215-24. PubMed ID: 26801880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photocarcinogenesis study of glycolic acid and salicylic acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 mice (simulated solar light and topical application study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2007 Sep; (524):1-242. PubMed ID: 21921960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.
    Anandharaj A; Cinghu S; Park WY
    Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):292-300. PubMed ID: 21367753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention.
    Bridgeman BB; Wang P; Ye B; Pelling JC; Volpert OV; Tong X
    Cell Signal; 2016 May; 28(5):460-468. PubMed ID: 26876613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.
    Clark CA; McEachern MD; Shah SH; Rong Y; Rong X; Smelley CL; Caldito GC; Abreo FW; Nathan CO
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1586-95. PubMed ID: 20851953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photocarcinogenesis study of aloe vera [CAS NO. 481-72-1(Aloe-emodin)] in SKH-1 mice (simulated solar light and topical application study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Sep; (553):7-33, 35-97, 99-103 passim. PubMed ID: 21031007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma.
    Lu Z; Wang J; Zheng Y; Yang S; Liu M; Chen X; Wang C; Hou G
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26725440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild-type and BK5.AktWT mice.
    Rho O; Kiguchi K; Jiang G; DiGiovanni J
    Mol Carcinog; 2014 Nov; 53(11):871-82. PubMed ID: 24114993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
    Vaid M; Sharma SD; Katiyar SK
    Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice.
    Blohm-Mangone K; Burkett NB; Tahsin S; Myrdal PB; Aodah A; Ho B; Janda J; McComas M; Saboda K; Roe DJ; Dong Z; Bode AM; Petricoin EF; Calvert VS; Curiel-Lewandrowski C; Alberts DS; Wondrak GT; Dickinson SE
    Cancer Prev Res (Phila); 2018 May; 11(5):265-278. PubMed ID: 29437671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
    Takeuchi H; Kondo Y; Fujiwara K; Kanzawa T; Aoki H; Mills GB; Kondo S
    Cancer Res; 2005 Apr; 65(8):3336-46. PubMed ID: 15833867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft.
    Bhola P; Banerjee S; Mukherjee J; Balasubramanium A; Arun V; Karim Z; Burrell K; Croul S; Gutmann DH; Guha A
    Int J Cancer; 2010 Jan; 126(2):563-71. PubMed ID: 19634141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antitumor effect of GDC-0941 alone and in combination with rapamycin in breast cancer cells.
    Zheng J; Zou X; Yao J
    Chemotherapy; 2012; 58(4):273-81. PubMed ID: 23006739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.
    Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR
    Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 analog-mediated protection against cholesterol-induced apoptosis via mammalian target of rapamycin activation in pancreatic βTC-6 cells -1mTORβTC-6.
    Zhou J; Wu J; Zheng F; Jin M; Li H
    J Diabetes; 2015 Mar; 7(2):231-9. PubMed ID: 24909811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin.
    Bermudez Y; Stratton SP; Curiel-Lewandrowski C; Warneke J; Hu C; Bowden GT; Dickinson SE; Dong Z; Bode AM; Saboda K; Brooks CA; Petricoin EF; Hurst CA; Alberts DS; Einspahr JG
    Cancer Prev Res (Phila); 2015 Aug; 8(8):720-8. PubMed ID: 26031292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
    Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
    Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway.
    Hung CM; Lin YC; Liu LC; Kuo SC; Ho CT; Way TD
    Chem Biol Interact; 2016 Dec; 260():1-12. PubMed ID: 27769712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.